M SCOTT HICKMAN, M.D.
Ophthalmology Physician in LAWRENCE, Kansas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
M SCOTT HICKMAN, M.D. reported a CMS MIPS final score of 74.9587/100 — below the 83.1 national average — and filed 933 Medicare Part D claims in 2023.
- 74.9587/100
- MIPS score · -8 vs avg
- 933
- Part D claims, 2023
- 79%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
M SCOTT HICKMAN, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
75 12th percentile higher than 12% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
M SCOTT HICKMAN, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about M SCOTT HICKMAN, M.D.?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Kansas
How Ophthalmology Physician compares to other specialties among Kansas providers
Ophthalmology Physician share within Kansas
Ophthalmology Physician is one of the more visible NUCC categories in Kansas
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
M SCOTT HICKMAN, M.D.'s 2023 MIPS final score plotted against the Ophthalmology Physician national average
- MIPS Final Score
- 74.9587/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Ophthalmology Physician) — 74.9587/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Ophthalmology Physician US NPIs
74.9587/100 MIPS final score — 8.1 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Ophthalmology Physician. Quality dim: 97.2588. Cost dim: 20.184.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
M SCOTT HICKMAN, M.D. appears in the CMS NPPES registry as a Ophthalmology Physician provider holding M.D. credentials at 4955 RESEARCH PARK WAY, LAWRENCE, KS, 66047, with a listed phone of (785) 424-8805. NPI 1114953965 was issued on 06/23/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what HICKMAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 933 prescription claims written by this provider, covering 216 Medicare beneficiaries and totaling roughly $52K in drug spend, split 21% brand-name and 79% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 74.9587/100 for the 2023 performance year (Quality 97.2588, Cost 20.184), compared with the national average of 83.1.
Ophthalmology Physician is a mid-sized specialty nationwide, with 22,090 enrolled providers across 56 states and an average of 1,420 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1114953965 |
|---|---|
| Specialty | Ophthalmology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 06/23/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm M SCOTT HICKMAN, M.D.'s current license status, disciplinary history, and board certifications with the Kansas Board of Healing Arts in Kansas before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for M SCOTT HICKMAN, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$198
Largest payer
Alcon Vision LLC
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Typical
21% brand-name claims vs 79% generic, on 933 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,397
- Total Day Supply
- 37,513
- Brand vs Generic
- 21% brand / 79% generic
- Brand Drug Cost
- $43K
- Generic Drug Cost
- $9K
- Antibiotic Claims
- 16
Patient Demographics
- Average Patient Age
- 77.3 years
- Avg HCC Risk Score
- 1.17
- Gender Split
- 62% female / 38% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What M SCOTT HICKMAN, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Latanoprost
Latanoprost
346 claims
- Brimonidine Tartrate
Brimonidine Tartrate
170 claims
- Timolol Maleate 85
Timolol Maleate
85 claims
- Prednisolone Acetate 62
Prednisolone Acetate
62 claims
- Neomycin-Polymyxin… 46
Neomycin-Polymyxin-Dexameth
46 claims
- Dorzolamide-Timolol 45
Dorzolamide-Timolol
45 claims
- Erythromycin 29
Erythromycin
29 claims
- Dorzolamide Hcl 27
Dorzolamide Hcl
27 claims
| Drug | Claims |
|---|---|
| Latanoprost | 346 |
| Brimonidine Tartrate | 170 |
| Timolol Maleate | 85 |
| Prednisolone Acetate | 62 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 46 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 45 |
| Erythromycin Erythromycin Base | 29 |
| Dorzolamide Hcl | 27 |
| Xiidra Lifitegrast | 18 |
| Alphagan P Brimonidine Tartrate | 13 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Ophthalmology Physician Overview
How M SCOTT HICKMAN, M.D. fits within the Ophthalmology Physician landscape nationally.
M SCOTT HICKMAN, M.D.'s 933 claims are below the specialty average of 1,420.
Nearby Ophthalmology Physician Providers in Kansas
Other clinicians with the same primary specialty enrolled in Kansas, drawn from the same CMS NPPES roster as HICKMAN.
Compare Ophthalmology Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Kansas
Frequently Asked Questions
What is M SCOTT HICKMAN, M.D.'s specialty? ▼
How much does M SCOTT HICKMAN, M.D. prescribe under Medicare Part D? ▼
What is M SCOTT HICKMAN, M.D.'s Medicare quality score? ▼
Where is M SCOTT HICKMAN, M.D. located? ▼
What is M SCOTT HICKMAN, M.D.'s NPI number? ▼
Does M SCOTT HICKMAN, M.D. prescribe more brand-name or generic drugs? ▼
How many Ophthalmology Physician providers are there in the US? ▼
What drugs does M SCOTT HICKMAN, M.D. prescribe most often? ▼
Does M SCOTT HICKMAN, M.D. accept Medicare? ▼
How can I verify M SCOTT HICKMAN, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology